Literature DB >> 8741733

CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated state.

D J Wilkinson1, M K Mansoura, P Y Watson, L S Smit, F S Collins, D C Dawson.   

Abstract

The functional roles of the two nucleotide binding folds, NBF1 and NBF2, in the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) were investigated by measuring the rates of activation and deactivation of CFTR Cl- conductance in Xenopus oocytes. Activation of wild-type CFTR in response to application of forskolin and 3-isobutyl-1-methylxanthine (IBMX) was described by a single exponential. Deactivation after washout of the cocktail consisted of two phases: an initial slow phase, described by a latency, and an exponential decline. Rate analysis of CFTR variants bearing analogous mutations in NBF1 and NBF2 permitted us to characterize amino acid substitutions according to their effects on the accessibility and stability of the active state. Access to the active state was very sensitive to substitutions for the invariant glycine (G551) in NBF1, where mutations to alanine (A), serine (S), or aspartic acid (D) reduced the apparent on rate by more than tenfold. The analogous substitutions in NBF2 (G1349) also reduced the on rate, by twofold to 10-fold, but substantially destabilized the active state as well, as judged by increased deactivation rates. In the putative ATP-binding pocket of either NBF, substitution of alanine, glutamine (Q), or arginine (R) for the invariant lysine (K464 or K1250) reduced the on rate similarly, by two- to fourfold. In contrast, these analogous substitutions produced opposite effects on the deactivation rate. NBF1 mutations destabilized the active state, whereas the analogous substitutions in NBF2 stabilized the active state such that activation was prolonged compared with that seen with wild-type CFTR. Substitution of asparagine (N) for a highly conserved aspartic acid (D572) in the ATP-binding pocket of NBF1 dramatically slowed the on rate and destabilized the active state. In contrast, the analogous substitution in NBF2 (D1370N) did not appreciably affect the on rate and markedly stabilized the active state. These results are consistent with a hypothesis for CFTR activation that invokes the binding and hydrolysis of ATP at NBF1 as a crucial step in activation, while at NBF2, ATP binding enhances access to the active state, but the rate of ATP hydrolysis controls the duration of the active state. The relatively slow time courses for activation and deactivation suggest that slow processes modulate ATP-dependent gating.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741733      PMCID: PMC2219252          DOI: 10.1085/jgp.107.1.103

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  52 in total

1.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.

Authors:  S C Hyde; P Emsley; M J Hartshorn; M M Mimmack; U Gileadi; S R Pearce; M P Gallagher; D R Gill; R E Hubbard; C F Higgins
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

3.  Site-directed mutagenesis of aspartic acid 372 at the ATP binding site of yeast phosphoglycerate kinase: over-expression and characterization of the mutant enzyme.

Authors:  P Minard; D J Bowen; L Hall; J A Littlechild; H C Watson
Journal:  Protein Eng       Date:  1990-05

4.  In vivo regulation of cyclic AMP phosphodiesterase in Xenopus oocytes. Stimulation by insulin and insulin-like growth factor 1.

Authors:  S E Sadler; J L Maller
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

5.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.

Authors:  G R Cutting; L M Kasch; B J Rosenstein; J Zielenski; L C Tsui; S E Antonarakis; H H Kazazian
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

7.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

Authors:  M L Drumm; H A Pope; W H Cliff; J M Rommens; S A Marvin; L C Tsui; F S Collins; R A Frizzell; J M Wilson
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

8.  The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.

Authors:  M R Carson; S M Travis; M J Welsh
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  Mutation of lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase and DNA helicase activities but not the ability to bind ATP.

Authors:  P Sung; D Higgins; L Prakash; S Prakash
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  19 in total

1.  Positioning of extracellular loop 1 affects pore gating of the cystic fibrosis transmembrane conductance regulator.

Authors:  Daniel T Infield; Guiying Cui; Christopher Kuang; Nael A McCarty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

2.  The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function.

Authors:  Runying Yang; Robert Scavetta; Xiu-Bao Chang
Journal:  Biochim Biophys Acta       Date:  2007-11-29

Review 3.  Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

4.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

5.  Regulation of recombinant cardiac cystic fibrosis transmembrane conductance regulator chloride channels by protein kinase C.

Authors:  J Yamazaki; F Britton; M L Collier; B Horowitz; J R Hume
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

6.  CFTR: Ligand exchange between a permeant anion ([Au(CN)2]-) and an engineered cysteine (T338C) blocks the pore.

Authors:  José R Serrano; Xuehong Liu; Erik R Borg; Christopher S Alexander; C Frank Shaw; David C Dawson
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

7.  Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore.

Authors:  M K Mansoura; S S Smith; A D Choi; N W Richards; T V Strong; M L Drumm; F S Collins; D C Dawson
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

Review 8.  Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.

Authors:  F S Seibert; T W Loo; D M Clarke; J R Riordan
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

9.  A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating.

Authors:  J Fu; H L Ji; A P Naren; K L Kirk
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.

Authors:  Christopher Alexander; Anthony Ivetac; Xuehong Liu; Yohei Norimatsu; Jose R Serrano; Allison Landstrom; Mark Sansom; David C Dawson
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.